It also addresses the FDA’s communications Using the applicant, the retention of data that guidance the SE report, confidentiality of the SE report, how an applicant can amend or withdraw an SE report, how an applicant might transfer ownership of an SE report to a new applicant and electronic submission with the SE report and amendments.The appli